Home » Topics » Regulatory

Regulatory
RSS

Subcutaneous IL-2 boosts CD4 cell counts in HIV-infected patients

March 26, 1997

Luvox cleared for OCD in children and adolescents

March 26, 1997

Antidepressant effects of NKH-477

March 26, 1997

CPMP approves lepirudin

March 24, 1997

New formulation of podofilox receives FDA approval

March 24, 1997

RPR seeks FDA approval for new indications for Lovenox

March 24, 1997

RPR files for U.S. approval of CFC-free asthma inhalater

March 21, 1997

FDA clears midazolam for use in children

March 21, 1997

Dermagraft-TC cleared for marketing

March 20, 1997

Tretinoin gel launched in the U.S.

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.